Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan;185(2):261-279.
doi: 10.1007/s10549-020-05954-2. Epub 2020 Oct 3.

Immune microenvironment in different molecular subtypes of ductal breast carcinoma

Mona Sadeghalvad  1   2   3 , Hamid-Reza Mohammadi-Motlagh  4 , Nima Rezaei  5   6   7   8
Affiliations
Review

Immune microenvironment in different molecular subtypes of ductal breast carcinoma

Mona Sadeghalvad et al. Breast Cancer Res Treat. 2021 Jan.

Abstract

Purpose: Ductal breast carcinoma as a heterogeneous disease has different molecular subtypes associated with clinical prognosis and patients' survival. The role of immune system as a consistent part of the tumor microenvironment (TME) has been documented in progression of ductal breast carcinoma. Here, we aimed to describe the important immune cells and the immune system-associated molecules in Ductal Carcinoma In situ (DCIS) and Invasive Ductal Carcinoma (IDC) with special emphasis on their associations with different molecular subtypes and patients' prognosis.

Results: The immune cells have a dual role in breast cancer (BC) microenvironment depending on the molecular subtype or tumor grade. These cells with different frequencies are present in the TME of DCIS and IDC. The presence of regulatory cells including Tregs, MDSC, Th2, Th17, M2 macrophages, HLADR- T cells, and Tγδ cells is related to more immunosuppressive microenvironment, especially in ER- and TN subtypes. In contrast, NK cells, CTL, Th, and Tfh cells are associated to the anti-tumor activity. These cells are higher in ER+ BC, although in other subtypes such as TN or HER2+ are associated with a favorable prognosis.

Conclusion: Determining the specific immune response in each subtype could be helpful in estimating the possible behavior of the tumor cells in TME. It is important to realize that different frequencies of immune cells in BC environment likely determine the patients' prognosis and their survival in each subtype. Therefore, elucidation of the distinct immune players in TME would be helpful toward developing targeted therapies in each subtype.

Keywords: Breast cancer; Ductal carcinoma; Immune cells; Molecular subtypes; Tumor microenvironment.

PubMed Disclaimer

References

    1. Siegel RL, Miller KD, Jemal A (2019) Cancer statistics. CA Cancer J Clin 69:7–34 - PubMed
    1. Hoon Tan P, Ellis I, Allison K, Brogi E et al (2020) The 2019 WHO classification of tumours of the breast. Histopathology. https://doi.org/10.1111/his.14091 - DOI
    1. Hanna WM, Parra-Herran C, Lu F-I, Slodkowska E, Rakovitch E, Nofech-Mozes S (2019) Ductal carcinoma in situ of the breast: an update for the pathologist in the era of individualized risk assessment and tailored therapies. Mod Pathol 32:896–915 - PubMed
    1. Lin EY, Gouon-Evans V, Nguyen AV, Pollard JW (2002) The macrophage growth factor CSF-1 in mammary gland development and tumor progression. J Mammary Gland Biol Neoplasia 7:147–162 - PubMed
    1. Colbert DC, McGarry MP, O'Neill K, Lee NA, Lee JJ (2005) Decreased size and survival of weanling mice in litters of IL-5–/–mice are a consequence of the IL-5 deficiency in nursing dams. Contemp Top Lab Anim Sci 44:53–55 - PubMed

Substances

LinkOut - more resources